Attend the Leena Peltonen Award lecture now at #eshg2026 with Nicola Whiffin from Oxford University and learn About her recent discovieries in rare diseases and the broader inclusion of non-coding variants in clinical genetic testing that led to the Leena Peltonen Award. Congratulations!
Attending #eshg2026?
I'll be happy to introduce you to #EKIDNA, a new citizen-science project that will assess #CKD genomics w high school students. See you there!
@silvidm.bsky.social will be there as well!
#finerenone effect in DM-free patients with
- eGFR of 25-60 ml/min x 1.73 m^2 & UACR of 200-500 mg/g
or
- eGFR of 25-90 ml/min x 1.73 m^2 & UACR of 500-3500 mg/g
#CKD
Finerenone in Persons with Chronic Kidney Disease without Diabetes | New England Journal of Medicine www.nejm.org/doi/full/10....
Illuminating discussion on the #ethics of control group treatment in #RCTs. Scroll down to find many possible examples in #nephrology - like a textbook
IRBs to keep eyes open
more on the issue of race-related equations in medicine from the #NEJM - reflections on #genetics
www.podbean.com/ep/pb-zprkr-...
From our group, you will also find an e-poster by Luisa Foco, @aldolabz.bsky.social et al on the role of blood pressure #PRS on resistant hypertension. Don't miss it
#CKD genomics @ #eshg2026?
Don't miss #CKDGen & #KidneyGen-Africa talks by
*** Pascal Schlosser C22.1 on #eGFR genomics
*** Sahar Ghasemi P16.062.B / LTB1.5 on #UACR genomics
*** Oyesola Ojewunmi C08.6 on African ancestry #GWAS
see you there!
@sfb1453.bsky.social @sfatumo.bsky.social
reflection on how using socially-constructed #race concepts may lead to imprecise and even dangerous decisions
www.nejm.org/doi/full/10....
Interested in doing a PhD with me in epidemiology on causal inference and triangulation? In beautiful Rotterdam no less.
www.werkenbijerasmusmc.nl/en/vacancy/1...
Pro tip: if you get to the interview stage, there WILL be a question about ice hockey
Cristian Pattaro
Cristian Pattaro
Cristian Pattaro
ABSTRACTBackground. Diabetic kidney disease (DKD) is a major cause of chronic kidney disease, with glomerular hyperfiltration contributing to its progressi
Many key questions in epidemiology are fundamentally causal. Yet, we often have to rely on assumptions that cannot be directly verified to judge whether an observed association truly reflects causalit...
In randomized trials, finerenone, a nonsteroidal mineralocorticoid receptor antagonist,
improved kidney and cardiovascular outcomes in patients with type 2 diabetes and chronic
kidney disease (CKD)...
We now know that humans are more than 99.9% genetically alike. So why does medicine still link certain diseases to race? And what do genetics actually tell us about race, ancestry, and disease?
A full...
Despite recognition that racial and ethnic categories are poor proxies for genetic diversity, race is still used to guide pharmaceutical use, posing risks of ineffectively low or dangerously high d...
Simulpub number 6 at #ERA26
Obi beats tacrolimus in membranous nephropathy
www.nejm.org/doi/full/10.... in NEJM
No surprise after MENTOR
Swapnil Hiremath 🍁🇨🇦
Studies of obinutuzumab, a type II anti-CD20 antibody, have shown efficacy in the treatment of hematologic cancers and autoimmune diseases. An evaluation of the efficacy and safety of obinutuzumab ...
